Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report) is projected to post its Q3 2026 results after the market closes on Tuesday, August 4th. Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. Arrowhead Pharmaceuticals had a negative net margin of 48.38% and a negative return on equity of 55.09%. Get Arrowhead Pharmaceuticals alerts:Arrowhead Pharmaceuticals Price PerformanceShares of ARWR opened at $84.65 on Monday. Read MoreReceive News & Ratings for Arrowhead Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arrowhead Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.